CompanyDrug

China Grand Pharmaceutical Receives FDA Approval for Post-Surgical Ophthalmic Drug GPN00833

CompanyDrug

Shanghai Fosun Pharma Gets NMPA Green Light for XS-02 Solid Tumor Clinical Study

CompanyDeals

Everest Medicines to Establish Integrated Kidney Disease Diagnosis and Treatment Ecosystem

CompanyDrug

Boehringer Ingelheim’s Spevigo Receives NMPA Approval for GPP Treatment in China

CompanyDeals

Zylox-Tonbridge Medical Technology Secures Licensing Deal with Avinger to Boost Device Portfolio

CompanyDeals

BeiGene Subsidiary Pi Health Cayman to be Merged in Deal Valued at $41.8 Million

CompanyDrug

Luye Pharma Launches Small-Cell Lung Cancer Treatment Zepzelca in Hong Kong and Macau

CompanyDeals

Proviva Therapeutics Secures $18 Million in Series A Financing to Advance PTX-912

Legal / IPPolicy / Regulatory

US Senate Committee Backs Bill to Restrict Chinese Biotechnology Firms’ Access to American Genetic Data

CompanyDrug

CARsgen Launches BCMA-Targeted CAR-T Therapy in China with High Price Point

CompanyDrug

Xian Janssen’s Tremfya Heads for Priority Review in China for Crohn’s Disease Treatment

CompanyDrug

EMA Reviews J&J’s Darzalex Subcutaneous Formulation for Newly Diagnosed Multiple Myeloma